58 related articles for article (PubMed ID: 16898500)
1. [Urinary TGF-beta1 excretion in children with renal cysts].
Biernacka A; Zoch-Zwierz WM; Wasilewska A; Porowski T; Niewiarowska A; Tenderenda E
Przegl Lek; 2006; 63 Suppl 3():94-6. PubMed ID: 16898500
[TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factor-β1 in children with obstructive uropathy.
Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.
Grenda R; Wühl E; Litwin M; Janas R; Sladowska J; Arbeiter K; Berg U; Caldas-Afonso A; Fischbach M; Mehls O; Sallay P; Schaefer F;
Nephrol Dial Transplant; 2007 Dec; 22(12):3487-94. PubMed ID: 17901069
[TBL] [Abstract][Full Text] [Related]
4. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
5. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
6. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
BJU Int; 2007 Apr; 99(4):899-903. PubMed ID: 17378848
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of TGF-β1 in children with primary IgA nephropathy].
Zhu HT; Ru L; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):749-53. PubMed ID: 25008886
[TBL] [Abstract][Full Text] [Related]
8. [The level of IGF-1 and TGF-beta-1 in the blood serum and the thyroid size in children with normal ioduria].
Brzozowska M; Kinalska I; Kretowski A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):215-20. PubMed ID: 16232359
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 in Balkan endemic nephropathy.
Dukanović L; Lezaić V; Miljković D; Momcilović M; Bukvić D; Marić I; Miljković Z; Marinković J; Mostarica-Stojković M
Nephron Clin Pract; 2009; 111(2):c127-32. PubMed ID: 19147994
[TBL] [Abstract][Full Text] [Related]
10. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
11. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
13. [Urinary excretion of fibrogenic and antifibrotic growth factors in type 1 diabetic patients: the interrelationship with diabetic nephropathy].
Bondar' IA; Klimontov VV; Parfent'eva EM; Romanov VV; Nadeev AP
Ter Arkh; 2012; 84(6):36-40. PubMed ID: 22997916
[TBL] [Abstract][Full Text] [Related]
14. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
15. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
[TBL] [Abstract][Full Text] [Related]
16. [Serum TGF-beta1 level in children with reflux nephropathy].
Zajaczkowska M; Bieniaś B; Borzecka H; Sikora P; Majewski M; Bojarska-Junak A
Przegl Lek; 2006; 63 Suppl 3():121-3. PubMed ID: 16898507
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease.
Guney I; Selcuk NY; Altintepe L; Atalay H; Başarali MK; Büyükbaş S
Ren Fail; 2009; 31(9):779-84. PubMed ID: 19925284
[TBL] [Abstract][Full Text] [Related]
18. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
20. [Influence of enteral nutrition therapy on serum angiogenic growth factors concentrations in children].
Wedrychowicz A; Kowalska-Duplaga K; Pieczarkowski S; Tomasik P; Spodaryk M; Fyderek K
Przegl Lek; 2010; 67(1):31-5. PubMed ID: 20509569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
